EPTIS – ESEAP: Greek EQA Scheme. Part 1 - Clinical chemistry (substrates, electrolytes, enzymes) (EPTIS-ID 138865)

ESEAP: Greek EQA Scheme. Part 1 - Clinical chemistry (substrates, electrolytes, enzymes)

EPTIS Ringversuch Nr. 138865 | Letze Änderung 2023-05-04 | URL: https://www.eptis.bam.de/pts138865 https://www.eptis.bam.de/pts138865

Name des Anbieters

Name des Anbieters

ESEAP

Ansässig in

Greece

Sprache(n)

Greek

Anmerkungen

A cycle of the program involves twelve distributions and covers a two year period. Following the analysis of two lyophilized controls of different concentrations, participants submit data via a web application and receive reports and information on their performance through the Internet. The analytes are statistically processed on the overall results, regardless of the methodology. After the elimination of outliers (elimination in two passes of all results > +2.5SD or < -2.5SD of the mean value), the “consensus” mean, namely the mean from all individual results, is used as target value. Statistical evaluation is also related to the method or the analyzer used and includes three different charts: distribution histograms, Levey-Jennings charts and Youden plots. The software of ESEAP permits the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results, as well as the evaluation of reproducibility of the measurements using 4 samples during each year. Furthermore, at the end of each two-year cycle, participants are assessed through an original scoring and ranking system, allowing them to follow their individual performance across time and their position among all other laboratories participating in the cycle. There is also a monthly program with twelve distributions of two samples per year.

Klassifizierung

Produktgruppen

Human test material

Prüfgebiete

Medical analysis

Technische Einzelheiten

Prüfobjekt	Prüfeigenschaft	Prüfmethode
Sera of human origin, lyophilized	Calcium	-
	Magnesium	-
	Potassium	-
	Sodium	-
	Chloride (Cl-)	-
	Glucose	-
	Cholesterol	-
	Iron	-
	Phosphorus	-
	Triglycerides	-
	Urea	-
	Albumin	-
	Aspartate aminotransferase	-
	Creatinine	-
	Gamma glutamyl transferase	-
	Uric acid	-
	Amylase	-
	Lactate dehydrogenase	-
	Protein, total	-
	Bilirubin, total	-
	Bilirubin, direct	-
	Cholesterol, HDL	-
	Phosphatase, alkaline	-
	Creatinine kinase	-
	Alanine aminotransferase	-

Ringversuchsziele

Zielgruppe des Ringversuchs

Clinical Laboratories

Relevante Rechtsvorschriften oder Normen

Weitere Ziele

validation of testing methods

Teilnehmerzahl

300

Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt)

Akkreditiert durch ESYD the Greek Accreditation Body auf der Grundlage von ISO 17043:2010 (Certificate No 820, 18/6/2012)

Recognised by TÜV Hellas on the basis of ISO 9001

Die Durchführung des Ringversuchs ist in Auftrag gegeben durch

Kosten

Teilnahmegebühr

335 Euro + VAT (bimonthly), 495 Euro + VAT (monthly)

Regelmässig durchgeführt

Ja (monthly or bimonthly)

Der Ringversuch wird durchgeführt seit

1994

Kontaktdaten des Anbieters

Anbieter

Kontaktperson

ESEAP
47, Alopekis str.
10676 Athens
Greece

Telefon: +30 2107292403
Fax: +30 2103645392
Web: http://www.eseap.gr

Dr. Alexander Haliassos
Telefon: +30 2107292403
Fax: +30 2103645392
E-Mail: info@eseap.gr

Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für Greece, Ms Vicky Nikou.

ESEAP: Greek EQA Scheme. Part 1 - Clinical chemistry (substrates, electrolytes, enzymes) EPTIS Ringversuch Nr. 138865 | Letze Änderung 2023-05-04 | URL: https://www.eptis.bam.de/pts138865 https://www.eptis.bam.de/pts138865

ESEAP: Greek EQA Scheme. Part 1 - Clinical chemistry (substrates, electrolytes, enzymes)

EPTIS Ringversuch Nr. 138865 | Letze Änderung 2023-05-04 | URL: https://www.eptis.bam.de/pts138865 https://www.eptis.bam.de/pts138865